共 12 条
[3]
Persistent high-risk human papillomavirus (HPV) infections as surrogate endpoints of progressive cervical disease. Potential new endpoint for efficacy studies with new-generation (non-HPV16/18) prophylactic HPV vaccines. K. Syrjanen. European Journal . 2011
[4]
A prospective study of age trends in cervical human papillomavirus acquisition and persistence in Guanacaste, Costa Rica. Castle Philip E,Schiffman Mark,Herrero Rolando,Hildesheim Allan,Rodriguez Ana Cecilia,Bratti M Concepcion,Sherman Mark E,Wacholder Sholom,Tarone Robert,Burk Robert D. The Journal of Infectious Diseases . 2005